| dbo:abstract |
The Patented Medicine Prices Review Board (French: Conseil d'examen du prix des médicaments brevetés) is a federal quasi-judicial regulatory and reporting agency in Canada with a mandate to protect consumers by ensuring that the prices of patented medication charged by manufacturers of patented drugs are not excessive. The board does this through its role as a regulator, and through its reporting on trends, research and development in the Canadian pharmaceutical industry. The board investigates, reviews and negotiates the price of individual drugs that are still under patent and which have no generic substitutes. It establishes the maximum prices that can be charged in Canada for patented drugs. (en) |
| dbo:budget |
1.03E7 (dbd:usDollar) |
| dbo:formationYear |
1987-01-01 (xsd:gYear) |
| dbo:headquarter |
dbr:Ottawa |
| dbo:jurisdiction |
dbr:Canada |
| dbo:leader |
dbr:Hon. |
| dbo:location |
dbr:Ottawa |
| dbo:numberOfEmployees |
74 (xsd:nonNegativeInteger) |
| dbo:thumbnail |
wiki-commons:Special:FilePath/PMPRB_logo.svg?width=300 |
| dbo:wikiPageExternalLink |
https://www.pmprb-cepmb.gc.ca/home http://pn.psychiatryonline.org/cgi/content/full/38/16/6-a%7Ctitle= https://archive.today/20040604024046/http:/pn.psychiatryonline.org/cgi/content/full/38/16/6-a%7Carchive-date=4 https://www.reuters.com/article/canada-pharmaceuticals-pricing/insight-rpt-in-canada-a-little-known-drug-regulator-shows-its-teeth-idUSL2N22J1ZQ%7Ctitle=In https://www.canada.ca/en/patented-medicine-prices-review.html |
| dbo:wikiPageID |
17830047 (xsd:integer) |
| dbo:wikiPageLength |
7124 (xsd:nonNegativeInteger) |
| dbo:wikiPageRevisionID |
1055140932 (xsd:integer) |
| dbo:wikiPageWikiLink |
dbr:Canada dbr:CA$ dbr:House_of_Commons_of_Canada dbr:Patty_Hajdu dbr:Reuters dbr:List_of_patent_medicines dbr:Generic_drug dbr:Patent_Act_(Canada) dbr:Quasi-judicial_body dbr:Minister_of_Health_(Canada) dbr:Patent dbr:Pharmaceutical_industry dbr:Ottawa dbr:Parliament_of_Canada dbc:Independent_government_agencies_of_Canada dbc:Pharmacy_organizations_in_Canada dbr:Generic_drugs dbr:Market_share dbr:Pharmaceutical_industry_in_Canada dbr:Hon. dbr:Compulsory_licensing dbr:MP_(Canada) |
| dbp:budget |
CA$10.3 million (en) |
| dbp:chief1Name |
Mitchell Levine (en) |
| dbp:chief1Position |
Chairperson (en) |
| dbp:chief2Name |
Mélanie Bourassa Forcier (en) |
| dbp:chief2Position |
Vice-chairperson (en) |
| dbp:chief3Name |
Douglas Clark (en) |
| dbp:chief3Position |
Executive Director (en) |
| dbp:employees |
74 (xsd:integer) |
| dbp:headquarters |
dbr:Ottawa |
| dbp:jurisdiction |
dbr:Canada |
| dbp:keydocument |
Patent Act (en) |
| dbp:logo |
PMPRB logo.svg (en) |
| dbp:minister1Name |
dbr:Patty_Hajdu dbr:Hon. |
| dbp:minister1Pfo |
dbr:Minister_of_Health_(Canada) |
| dbp:name |
Patented Medicine Prices Review Board (en) |
| dbp:nativeName |
(en) |
| dbp:website |
https://www.canada.ca/en/patented-medicine-prices-review.html |
| dbp:wikiPageUsesTemplate |
dbt:Authority_control dbt:Cite_journal dbt:Cite_news dbt:Reflist dbt:Rp dbt:Start_date_and_age dbt:Infobox_government_agency |
| dct:subject |
dbc:Independent_government_agencies_of_Canada dbc:Pharmacy_organizations_in_Canada |
| gold:hypernym |
dbr:Agency |
| schema:sameAs |
http://viaf.org/viaf/154307469 |
| rdf:type |
owl:Thing schema:Organization dul:Agent dul:SocialPerson dbo:Agent wikidata:Q24229398 wikidata:Q327333 wikidata:Q43229 dbo:GovernmentAgency dbo:Organisation |
| rdfs:comment |
The Patented Medicine Prices Review Board (French: Conseil d'examen du prix des médicaments brevetés) is a federal quasi-judicial regulatory and reporting agency in Canada with a mandate to protect consumers by ensuring that the prices of patented medication charged by manufacturers of patented drugs are not excessive. The board does this through its role as a regulator, and through its reporting on trends, research and development in the Canadian pharmaceutical industry. (en) |
| rdfs:label |
Patented Medicine Prices Review Board (en) |
| owl:sameAs |
freebase:Patented Medicine Prices Review Board http://viaf.org/viaf/154307469 http://d-nb.info/gnd/5011999-0 wikidata:Patented Medicine Prices Review Board https://global.dbpedia.org/id/4tE4Y |
| prov:wasDerivedFrom |
wikipedia-en:Patented_Medicine_Prices_Review_Board?oldid=1055140932&ns=0 |
| foaf:depiction |
wiki-commons:Special:FilePath/PMPRB_logo.svg |
| foaf:homepage |
https://www.canada.ca/en/patented-medicine-prices-review.html |
| foaf:isPrimaryTopicOf |
wikipedia-en:Patented_Medicine_Prices_Review_Board |
| is dbo:wikiPageRedirects of |
dbr:PMPRB dbr:Patent_Medicines_Pricing_Review_Board dbr:Patented_Medicines_Pricing_Review_Board dbr:Pmprb |
| is dbo:wikiPageWikiLink of |
dbr:Defined_daily_dose dbr:Prescription_drug_prices_in_the_United_States dbr:.gc.ca dbr:Minister_of_Health_(Canada) dbr:BIOTECanada dbr:Healthcare_industry dbr:Eculizumab dbr:Health_Canada dbr:Canadian_House_of_Commons_Standing_Committee_on_Health dbr:Medicare_(Canada) dbr:Pharmaceutical_policy dbr:Structure_of_the_Canadian_federal_government dbr:PMPRB dbr:Patent_Medicines_Pricing_Review_Board dbr:Patented_Medicines_Pricing_Review_Board dbr:Pmprb |
| is foaf:primaryTopic of |
wikipedia-en:Patented_Medicine_Prices_Review_Board |
